Current filters:


Popular Filters

1 to 25 of 8447 results

Lilly's Cyramza first FDA-approved drug for advanced gastric cancer after prior chemo


The US Food and Drug Administration has approved pharma major Eli Lilly’s Cyramza (ramucirumab) as…

CyramzaEli LillyNorth AmericaOncologyPharmaceuticalRegulationUSA

AbbVie files NDA for oral, interferon-free treatment of hepatitis C


US drugmaker AbbVie has submitted its New Drug Application to the US Food and Drug Administration for…

AbbVieAnti-viralsEnanta PharmaceuticalsFinancialNorth AmericaPharmaceuticalRegulationUSA

Epizyme earns $4 million milestone under GSK collaboration


US clinical-stage biopharma firm Epizyme announced the achievement of the lead candidate milestone for…


Vietnam's pharma market among the fastest growing in Southeast Asia


Vietnam is currently one of the fastest growing pharmaceutical markets in Southeast Asia, recording a…

Asia-PacificMarkets & MarketingPatentsPharmaceuticalPricing

Novartis swaps products with GlaxoSmithKline, sells unit to Lilly


In what looks like a significant restructuring of company focuses, Swiss drug major Novartis and UK peer…

Eli LillyGlaxoSmithKlineMergers & AcquisitionsNovartisPharmaceuticalVaccines

AusBiotech to submit to Senate’s Australian innovation system inquiry


Trade group AusBiotech is preparing a submission, following the Senate's referral of an inquiry into…


Sentinel Oncology in deal with Oncothyreon worth a potential $174 million


UK-based small molecule drug discovered Sentinel Oncology has signed a collaboration agreement with the…

BiotechnologyLicensingOncologyOncothyreonResearchSentinel Oncology

Sanofi divests Cell Therapy and Regenerative Medicine business to Aastrom


US cardiovascular drug developer Aastrom Biosciences has entered into a definitive agreement to acquire…

Aastrom BiosciencesBiotechnologyMergers & AcquisitionsSanofi

Greek health system victim of debt crisis but reform now possible, say experts


Greece's health care system was among the victims of the debt crisis which began four years ago, according…


Novartis appoints Jeff George as Division Head, Alcon and Richard Francis as Division Head, Sandoz

Novartis appoints Jeff George as Division Head, Alcon and Richard Francis as Division Head, Sandoz


Swiss drug major Novartis has announced the appointment of Jeff George as Division Head of Alcon and…

AlconBoardroomNorthern EuropeNovartisPharmaceuticalSandoz

e-Therapeutics announces appointment of Steve Medlicott as Finance Director

e-Therapeutics announces appointment of Steve Medlicott as Finance Director


UK-based drug discovery and development company e-Therapeutics has announced the appointment of Steve…


Adcock Ingram appoints CEO

Adcock Ingram appoints CEO


South African drugmaker Adcock Ingram has announced the appointment of Kevin Wakeford (pictured) as Chief…

Adcock IngramBoardroomPharmaceuticalSouth Africa

Mega-mergers could be back in pharma sector, but is Pfizer bid for AstraZeneca likely to succeed?


This weekend’s revelation about a possible acquisition of Anglo-Swedish drug major AstraZeneca by the…

AstraZenecaMergers & AcquisitionsPfizer

US FDA clears pathway for Sarepta’s eteplirsen filing by year end


US RNA-based drug developer Sarepta Therapeutics it plans to submit a New Drug Application to the US…

BiotechnologyeteplirsenNorth AmericaRare diseasesRegulationSarepta TherapeuticsUSA

Indian regulator seeks to address the nation’s substandard drugs problem

Indian regulator seeks to address the nation’s substandard drugs problem


In what is something of an indictment of India’s pharmaceutical industry, the Drug Controller General…


Biogen Idec exercises option for Amunix’ XTENylated Factor VIII


US privately-held biotech firm Amunix Operating says that Biogen Idec has exercised its option to enter…

AmunixBiogen IdecBiotechnologyHematologyLicensing

Pfizer said to be eyeing a $100 billion bid for AstraZeneca


USA-based Pfizer, the world’s largest pharma company by sales, looks to be on the acquisition trail,…

AstraZenecaMergers & AcquisitionsPfizerPharmaceutical

NHS England agrees funding for Gilead’s hepatitis C drug Sovaldi


NHS England has approved an £18.7 million ($31.3 million) investment in a new drug for the treatment…

Anti-viralsBiotechnologyFinancialGilead SciencesHealthcareNorthern EuropeSovaldiUK

First Asian approval for ophthalmic drug Jetrea, in Malaysia


Belgian biotech firm ThromboGenics NV revealed today that Jetrea (ocriplasmin) has been approved in Malaysia…


EMA update on stolen vials of Herceptin


The European Medicines Agency has provided an update on the latest information relating to the stolen…


FDA approves Merck’s Ragwitek for short ragweed pollen allergies


The US Food and Drug Administration has approved US pharma giant Merck & Co’s Biological License Application…

ALK AbelloImmunologicalsMerck & CoNorth AmericaPharmaceuticalRagwitekRegulationUSA

OPKO to buy Israel’s Inspiro, gaining rights to new drug delivery technology


US biopharma company OPKO Health has entered into a definitive agreement to acquire Inspiro Medical an…

Inspiro MedicalMergers & AcquisitionsOPKO HealthPharmaceuticalRespiratory and Pulmonary

Canadian approval for GSK’s Incruse Ellipta as a treatment for COPD


UK pharma giant GlaxoSmithKline says that Incruse Ellipta (umeclidinium) has received market authorization…

CanadaGlaxoSmithKlineIncruse ElliptaNorth AmericaPharmaceuticalRegulationRespiratory and Pulmonary

1 to 25 of 8447 results

Back to top